Dr. Andreas Shoeck
Claim this profileActivMed Practices and Research
Studies Migraine
Studies Vestibular Migraine
4 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Andreas Shoeck is currently running
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Galcanezumab
for Migraine
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Recruiting1 award Phase 31 criteria
More about Andreas Shoeck
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Andreas Shoeck has experience with
- Lasmiditan
- Galcanezumab
- Placebo
Breakdown of trials Andreas Shoeck has run
Migraine
Vestibular Migraine
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Andreas Shoeck specialize in?
Is Andreas Shoeck currently recruiting for clinical trials?
Are there any treatments that Andreas Shoeck has studied deeply?
What is the best way to schedule an appointment with Andreas Shoeck?
What is the office address of Andreas Shoeck?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.